Spine BioRestorative Therapies Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc Disease byJosh SandbergFebruary 5, 2024
Biologics Spine BioRestorative Therapies Announces Activation of Northwell Health in the Company’s Phase 2 Clinical Trial Targeting Chronic Lumbar Disc Disease byJosh SandbergSeptember 8, 2023
Biologics BioRestorative Therapies Announces Key Milestone of Dosing Completion in Safety Cohort of Phase 2 Trial Targeting Chronic Lumbar Disc Disease byJosh SandbergJune 12, 2023
Biologics Spine BioRestorative Therapies Announces First Patient Enrolled for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD) byChris StewartJune 30, 2022
Biologics Spine BioRestorative Therapies Announces Clinical Trial Contract with Second Site for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD) byChris StewartJune 22, 2022
Biologics Spine BioRestorative Therapies Announces Clinical Site Initiation for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD) byJosh SandbergJune 13, 2022
Biologics Spine BioRestorative Therapies Announces CRO Agreement with PRC Clinical for its BRTX-100 Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease byJosh SandbergDecember 21, 2021
COVID-19 Hospitals Regulatory This Policy Expert Explains Why The United States Will See An Increase In Non-Coronavirus Deaths (And How We Can Stop It) byJosh SandbergApril 8, 2020
COVID-19 Hospitals Regulatory Why Some COVID-19 Patients Crash: The Body’s Immune System Might Be To Blame byJosh SandbergApril 7, 2020
COVID-19 Hospitals Regulatory 8 strains of the coronavirus are circling the globe. Here’s what clues they’re giving scientists byJosh SandbergMarch 27, 2020
